» Articles » PMID: 26622257

D-dimer Testing for Safe Exclusion and Risk Stratification in Patients with Acute Pulmonary Embolism in Primary Care

Overview
Journal J Res Med Sci
Specialty General Medicine
Date 2015 Dec 2
PMID 26622257
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Safe exclusion and risk stratification are currently recommended for the initial management of patients with acute pulmonary embolism (APE). The aim of this study was to assess the safe exclusion and risk stratification value of D-dimer (DD) for APE when tested at the beginning of admission.

Materials And Methods: All consecutive Chinese APE patients and controls were recruited from January 2010 to December 2012. All measurements of serum indexes were made in duplicate and blinded to the patients' status. All the 40 patients with the first episode of APE were confirmed by multi-detector computed tomographic pulmonary angiography. The plasma prothrombin time (PT), activated partial thromboplastin time, thrombin time, fibrinogen, and DD levels were measured within 24 h of admission. We used the Mann-Whitney U-test to determine the differences between groups and drew receiver operator characteristic curve to evaluate the indexes' value in the APE screening.

Results: The PT and DD in the APE group were significantly higher than those in the disease control group (P < 0.05). Taking PT and DD as the useful screening tests for APE and AUC was 0.765 and 0.822, respectively. DD yielded the higher screening efficiency, with DD >1820 μg/L as cut-off value, the sensitivity, specificity, positive and negative predictive value was 82.5%, 75.2%, 56.9%, and 91.6%, respectively.

Conclusion: The patients with APE showed significant higher DD levels compared with disease controls, suggesting a negative qualitative DD test result can safely and efficiently exclude APE in primary care.

References
1.
den Exter P, Klok F, Huisman M . Diagnosis of pulmonary embolism: Advances and pitfalls. Best Pract Res Clin Haematol. 2012; 25(3):295-302. DOI: 10.1016/j.beha.2012.06.002. View

2.
Lobo J, Zorrilla V, Aizpuru F, Grau E, Jimenez D, Palareti G . D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. J Thromb Haemost. 2009; 7(11):1795-801. DOI: 10.1111/j.1538-7836.2009.03576.x. View

3.
Warren D, Matthews S . Pulmonary embolism: investigation of the clinically assessed intermediate risk subgroup. Br J Radiol. 2011; 85(1009):37-43. PMC: 3473929. DOI: 10.1259/bjr/17451818. View

4.
Gupta R, Kakarla R, Kirshenbaum K, Tapson V . D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism. AJR Am J Roentgenol. 2009; 193(2):425-30. DOI: 10.2214/AJR.08.2186. View

5.
Huang C, Lin Y, Lin Y, Chang S, Lo L, Hu Y . Risk stratification and clinical outcomes in patients with acute pulmonary embolism. Clin Biochem. 2011; 44(13):1110-1115. DOI: 10.1016/j.clinbiochem.2011.06.077. View